Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-028330
Filing Date
2019-05-08
Accepted
2019-05-08 18:36:03
Documents
2
Period of Report
2019-05-08

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 5967
2 POA DOCUMENT poa.txt EX-24.3_851420 3876
  Complete submission text file 0001209191-19-028330.txt   11219
Mailing Address 269 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080
Business Address 269 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080 415-910-5717
Cortexyme, Inc. (Issuer) CIK: 0001662774 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O CORTEXYME, INC. 269 EAST GRAND AVE. SOUTH SAN FRANCISCO CA 94080
Business Address
Holsinger Leslie (Reporting) CIK: 0001770821 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38890 | Film No.: 19808185